Importance of the Liposomal Cationic Lipid Content and Type in Tumor Vascular Targeting: Physicochemical Characterization and In Vitro Studies Using Human Primary and Transformed Endothelial Cells

REFERENCES

• Ades E. A., Candal F. J., Swerlick R. A., George V. G., Summers S., Bosse D. C., Lawley T. J. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. The Journal of Investigative Dermatology 1992; 99: 683–690
   PubMed Web of Science ®Google Scholar
• Baldwin A. L., Wu N. Z., Stein D. L. Endothelial surface charge of intestinal mucosal capillaries and its modulation by dextran. Microvascular Research 1991; 42: 160–178
   PubMed Web of Science ®Google Scholar
• Belotti D., Vergani V., Drudis T., Borsotti P., Pitelli M. R., Viale G., Giavassi R., Taraboletti G. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clinical Cancer Research 1996; 2: 1843–1849
   PubMed Web of Science ®Google Scholar
• Brower V. Tumor angiogenesis-new drugs on the block. Nature Biotechnology 1999; 17: 963–968
   PubMed Web of Science ®Google Scholar
• Burrows F. J., Thorpe P. E. Vascular targeting-a new approach to the therapy of solid tumors. Pharmacological Therapy 1994; 64: 155–174
   PubMed Web of Science ®Google Scholar
• Campbell R. B. Tumor physiology and delivery of nanopharmaceuticals. Anti-Cancer Agents in Medicinal Chemistry 2006; 6: 501–510
   PubMedGoogle Scholar
• Campbell R. B., Balasubramanian S. V., Straubinger R. M. Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. Journal of Pharmaceutical Sciences 2001a; 90: 1091–1105
   PubMed Web of Science ®Google Scholar
• Campbell R. B., Balasubramanian S. V., Straubinger R. M. Physical properties of phospholipid-cationic lipid interactions: Influences on domain structure, liposome size and cellular uptake. Biochimica et Biophysica Acta 2001b; 15: 1227–1539
   Google Scholar
• Campbell R. B., Fukumura D., Brown E. B., Mazzola M. L., Izumi Y., Jain R. K., Torchilin V. P., Munn L. L. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Research 2002; 62: 6831–6836
   PubMed Web of Science ®Google Scholar
• Chaplin D. J., Dougherty G. J. Tumour vasculature as a target for cancer therapy. British Journal of Cancer 1999; 1: 57–64
   Google Scholar
• Charonis A. S., Wissig S. L. Anionic sites in basement membranes. Differences in their electrostatic properties in continuous and fenestrated capillaries. Microvascular Research 1983; 25: 265–285
   PubMed Web of Science ®Google Scholar
• Dandamudi S., Campbell R. B. Development and characterization of magnetic cationic liposomes for targeting tumor microvasculature. Biochimica et Biophysica Acta 2007a; 1768: 427–438
   PubMed Web of Science ®Google Scholar
• Dandamudi S., Campbell R. B. The drug loading, cytotoxicity and tumor vascular targeting characteristics of magnetite in magnetic drug targeting. Biomaterials 2007b; 28: 4673–4683
   PubMed Web of Science ®Google Scholar
• Dass C. R., Choong P. F. Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: Lessons from gene therapy. Cancer Cell International 2006; 6: 17
   PubMed Web of Science ®Google Scholar
• Denekamp J. Vasculature as a target for tumor therapy. Progress in Applied Microcirculation 1984; 4: 28–438
   Google Scholar
• Denekamp J., Hobson B. Endothelial-cell proliferation in experimental tumours. British Journal of Cancer 1982; 46: 711–720
   PubMed Web of Science ®Google Scholar
• Emmenegger U., Morton G. C., Francia G., Shaked Y., Franco M., Weinerman A., Man S., Kerbel R. S. Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: A well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia. Cancer Research 2006; 66: 1664–1674
   PubMed Web of Science ®Google Scholar
• Evans R. R., Calmels T. P., Pitt B. R., Brookens M. A., Johnson C. S., Modzelewski R. A., Lazo J. S. Gene therapy and endothelial cell targeting for cancer. Annals of the New York Academy of Sciences 1994; 716: 257–264
   PubMed Web of Science ®Google Scholar
• Felgner P., Gadek T., Holm M., Roman R., Chan H., Wenz M., Northrop J., Ringold G., Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences of the United States of America 1987; 84: 7413–7417
   PubMed Web of Science ®Google Scholar
• Folkman J. The role of angiogenesis in tumor growth. Seminars in Cancer Biology 1992; 3: 65–71
   PubMedGoogle Scholar
• Folkman J. Tumor angiogenesis: Therapeutic implications. New England Journal of Medicine 1971; 285: 1182–1186
   PubMed Web of Science ®Google Scholar
• Gately S., Kerbel R. S. Antiangiogenic scheduling of lower dose cancer chemotherapy. Cancer Journal 2001; 7: 427–436
   PubMed Web of Science ®Google Scholar
• Hardebo J. E., Kahrstrom J. Endothelial negative surface charge areas and blood-brain barrier function. Acta Physiological Scandinavica 1985; 125: 495–499
   PubMedGoogle Scholar
• Jain R. K. The next frontier of molecular medicine: Delivery of therapeutics. Nature Medicine 1998; 4: 655–657
   PubMed Web of Science ®Google Scholar
• Jain R. K. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer and Metastasis Reviews 1990; 9: 253–266
   PubMed Web of Science ®Google Scholar
• Kalra A. V., Campbell R. B. Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting. Pharmaceutical Research 2006; 23: 2809–2817
   PubMed Web of Science ®Google Scholar
• Kato Y., Mawatari H., Nishimura S., Sakura N., Ueda K. Determination of etoposide serum concentration in small pediatric samples by an improved method of reversed-phase high-performance liquid chromatography. Acta Medica Okayama 2003; 57: 21–24
   PubMed Web of Science ®Google Scholar
• Kerbel R. S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents. Bioessays 1991; 13: 31–36
   PubMed Web of Science ®Google Scholar
• Kunstfeld R., Weckenhauser G., Michaelis U., Teifel M., Umek W., Naujoks K., Wolff K., Petzelbauer P. Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a “humanized” SCID mouse model. Journal of Investigative Dermatology 2003; 120: 476–482
   PubMed Web of Science ®Google Scholar
• Lee C. M., Tanaka T., Murai T., Kondo M., Kimura J. S. W., Kitagawa T., Ito T., Matsuda H., Matsuda M. M. Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Research 2002; 62: 4282–4288
   PubMed Web of Science ®Google Scholar
• Levchenko T. S., Rammohan R., Lukyanov A. N., Whiteman K. R., Torchilin V. P. Liposome clearance in mice: The effect of a separate and combined presence of surface charge and polymer coating. International Journal of Pharmaceutics 2002; 240: 95–102
   PubMed Web of Science ®Google Scholar
• McLean J. W., Fox E. A., Baluk P., Bolton P. B., Haskell A., Pearlman R., Thurston G., Umemoto E. Y., McDonald D. M. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. American Journal of Physiology 1997; 273: 387–404
   PubMed Web of Science ®Google Scholar
• Mislick K. A., Baldeschwieler J. D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 12349–12354
   PubMed Web of Science ®Google Scholar
• Mounkes L. C., Zhong Cipres W., Palacin G., Heath T. D., Debs R. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. The Journal of Biological Chemistry 1998; 1998: 26164–26170
   Google Scholar
• Pasquier E., Honore S., Pourroy B., Jordan M. A., Lehmann M., Briand C., Braguer D. Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells. Cancer Research 2005; 65: 2433–40
   PubMed Web of Science ®Google Scholar
• Ran S., Downes A., Thorpe P. E. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Research 2002; 62: 6132–40
   PubMed Web of Science ®Google Scholar
• Roberts W. G., Palade G. E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Research 1997; 57: 765–772
   PubMed Web of Science ®Google Scholar
• Sengupta S., Tyagi P., Chandra S., Kochupillai V., Gupta S. K. Encapsulation in cationic liposomes enhances antitumour efficacy and reduces the toxicity of etoposide, a topo-isomerase II inhibitor. Pharmacology 2001; 62: 163–171
   PubMed Web of Science ®Google Scholar
• Sengupta S., Tyagi P., Velpandian T., Gupta Y. K., Gupta S. K. Etoposide encapsulated in positively charged liposomes: Pharmacokinetic studies in mice and formulation stability studies. Pharmacological Research 2000; 42: 459–464
   PubMed Web of Science ®Google Scholar
• Simionescu M., Simionescu N., Santoro F., Palade G. E. Differentiated microdomains of the luminal plasmalemma of murine muscle capillaries: Segmental variations in young and old animals. The Journal of Cell Biology 1985; 100: 1396–1407
   PubMed Web of Science ®Google Scholar
• Skehan P., Storeng R., Scudiero D., Monks A., McMohan J., Warren J. T., Bokesch H., Kenney S., Boyd M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute 1990; 82: 1107–1112
   PubMed Web of Science ®Google Scholar
• Strieth S., Eichhorn M. E., Sauer B., Dellian M. Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature. International Journal of Cancer 2004; 110: 117–124
   PubMed Web of Science ®Google Scholar
• Strieth S., Eichhorn M. E., Sauer B., Schulze B., Teifel M., Michaelis U., Dellian M. Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposome impairs functional tumor microvasculature. International Journal of Cancer 2004; 110: 117–124
   PubMed Web of Science ®Google Scholar
• Takahashi Y., Kitadai Y., Bucans C. D., Clearly K. R., Ellis L. M. Expression of vascular endothelial growth factor and its receptor, KDR correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Research 1995; 55: 3964–3968
   PubMed Web of Science ®Google Scholar
• Thurston G., McLean J. W., Rizen M., Baluk P., Haskell A., Murphy T. J., Hanahan D., McDonald D. M. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. Journal of Clinical Investigation 1998; 101: 1401–1413
   PubMed Web of Science ®Google Scholar
• Vijayagopal P., Figueoroa J. E., Levine E. A. Altered composition and increased endothelial cell proliferative activity of proteoglycans isolated from breast carcinoma. Journal of Surgical Oncology 1998; 68: 250–254
   PubMed Web of Science ®Google Scholar
• Vincent S., DePace D., Finkelstein S. Distribution of anionic sites on the capillary endothelium in an experimental brain tumor model. Microcirculation, Endothelium, Lymphatics 1988; 1988: 45–67
   Google Scholar
• Zuidam N. J., Barenholz Y. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin. Biochimica Biophysica Acta 1997; 1329: 211–222
   PubMed Web of Science ®Google Scholar